Citrobacter koseri Cellulitis During Anti-CD20 Monoclonal Antibody (Ofatumumab) Treatment for B-cell Chronic Lymphocytic Leukaemia

被引：6
|
作者：
Kluger, Nicolas [1 ]
Cartron, Guillaume [2 ]
Bessis, Didier [1 ]
Guillot, Bernard [1 ]
Girard, Celine [1 ]
机构：
[1] Univ Montpellier 1, CHU Montpellier, Hop St Eloi, Dept Dermatol, FR-34295 Montpellier, France
[2] Univ Montpellier 1, CHU Montpellier, Hop Lapeyronie, Dept Haematol, FR-34295 Montpellier, France
来源：
ACTA DERMATO-VENEREOLOGICA | 2010年 / 90卷 / 01期
关键词：
GRAM-NEGATIVE FOLLICULITIS; DIVERSUS;
D O I：
10.2340/00015555-0762
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [1] Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies
    Cheson, Bruce D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) : 3525 - 3530
  • [2] Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia
    Chuda, Ravindra R.
    Vishnu, Prakash
    Aboulafia, David
    CURRENT DRUG THERAPY, 2012, 7 (04) : 281 - 289
  • [3] Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia
    Bauer, Kathrin
    Rancea, Michaela
    Roloff, Verena
    Elter, Thomas
    Hallek, Michael
    Engert, Andreas
    Skoetz, Nicole
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (11):
  • [4] Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for Treatment of Refractory Chronic Lymphocytic Leukemia
    Nightingale, Ginah
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (10) : 1248 - 1255
  • [5] Ofatumumab: a novel, fully human anti-CD20 monoclonal antibody for the treatment of chronic lymphocytic leukemia
    Barth, Matthew J.
    Czuczman, Myron S.
    FUTURE ONCOLOGY, 2013, 9 (12) : 1829 - 1839
  • [6] Ofatumumab: A New CD20 Monoclonal Antibody Therapy for B-Cell Chronic Lymphocytic Leukemia
    O'Brien, Susan
    Osterborg, Anders
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (05): : 361 - 368
  • [7] Ofatumumab, a human anti-CD20 monoclonal antibody
    Osterborg, Anders
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (03) : 439 - 449
  • [8] Selection of B-cell chronic lymphocytic leukemia cell variants by therapy with anti-CD20 monoclonal antibody rituximab
    Pickartz, T
    Ringel, F
    Wedde, M
    Renz, H
    Klein, A
    von Neuhoff, N
    Dreger, P
    Kreuzer, KA
    Schmidt, CA
    Srock, S
    Schoeler, D
    Schriever, F
    EXPERIMENTAL HEMATOLOGY, 2001, 29 (12) : 1410 - 1416
  • [9] Ofatumumab: a novel monoclonal anti-CD20 antibody
    Lin, Thomas S.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2010, 3 : 51 - 59
  • [10] Ofatumumab, the first human anti-CD20 monoclonal antibody for the treatment of B cell hematologic malignancies
    Gupta, Ira V.
    Jewell, Roxanne C.
    PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: PRIX GALIEN 2011, 2012, 1263 : 43 - 56
12345